HRS4R
Vull donar
Brugada R, Hong K, Dumaine R, Cordeiro J, Gaita F, Borggrefe M, Menendez TM, Brugada J, Pollevick GD, Wolpert C, Burashnikov E, Matsuo K, Wu YS, Guerchicoff A, Bianchi F, Giustetto C, Schimpf R, Brugada P, Antzelevitch C

Sudden death associated with short-QT syndrome linked to mutations in HERG.

Circulation, 2004, 109, 30-35 dx.doi.org/10.1161/01.CIR.0000109482.92774.3A
Menendez JA, Lupu R

Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2004, 52, 414-426
Lainez B, Fernandez-Real JM, Romero X, Esplugues E, Cañete JD, Ricart W, Engel P

Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2.

INTERNATIONAL IMMUNOLOGY, 2004, 16, 169-177 dx.doi.org/10.1093/intimm/dxh014
Hong K, Berruezo-Sanchez A, Poungvarin N, Oliva A, Vatta M, Brugada J, Brugada P, Towbin JA, Dumaine R, Piñero-Galvez C, Antzelevitch C, Brugada R

Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15, 64-69 dx.doi.org/10.1046/j.1540-8167.2004.03341.x
Menendez JA, Mehmi I, Verma VA, Teng PK, Lupu R

Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.

MOLECULAR CARCINOGENESIS, 2004, 41, 164-178 dx.doi.org/10.1002/mc.20054
Megia A, Gallart L, Fernández-Real JM, Vendrell J, Simón I, Gutierrez C, Richart C

Mannose-binding lectin gene polymorphisms are associated with gestational diabetes mellitus

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89, 5081-5087 dx.doi.org/10.1210/jc.2004-0211
Menendez JA, Colomer R, Lupu R

Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.

ONCOLOGY REPORTS, 2004, 12, 411-422
López-Bermejo A, Casano-Sancho P, Fernández-Real JM, Kihara S, Funahashi T, Rodríguez-Hierro F, Ricart W, Ibañez L

Both intrauterine growth restriction and postnatal growth influence childhood serum concentrations of adiponectin

CLINICAL ENDOCRINOLOGY, 2004, 61, 339-346 dx.doi.org/10.1111/j.1365-2265.2004.02102.x
Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, Dávalos A

Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke.

Stroke, 2003, 34, 40-46 dx.doi.org/10.1161/01.STR.0000046764.57344.31
Martínez-Rodríguez JE, Lin L, Iranzo A, Genis D, Martí MJ, Santamaria J, Mignot E

Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.

Sleep, 2003, 26, 287-290 dx.doi.org/10.1093/sleep/26.3.287
Costa A, Fernández-Real JM, Vendrell J, Broch M, Casamitjana R, Ricart W, Conget I

Lower rate of tumor necrosis factor-alpha -863A allele and higher concentration of tumor necrosis factor-alpha receptor 2 in first-degree relatives of subjects with type 2 diabetes.

METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52, 1068-1071 dx.doi.org/10.1016/S0026-0495(03)00108-2
Antzelevitch C, Brugada P, Brugada J, Brugada R, Towbin JA, Nademanee K

Brugada syndrome: 1992-2002: a historical perspective.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41, 1665-1671 dx.doi.org/10.1016/S0735-1097(03)00310-3
Fernández-Real JM, López-Bermejo A, Casamitjana R, Ricart W

Novel interactions of adiponectin with the endocrine system and inflammatory parameters.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88, 2714-2718 dx.doi.org/10.1210/jc.2002-021583
Brugada P, Brugada R, Mont L, Rivero M, Geelen P, Brugada J

Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14, 455-457 dx.doi.org/10.1046/j.1540-8167.2003.02517.x
Torres MH, Salazar LM, Vanegas M, Guzman F, Rodriguez R, Silva Y, Rosas J, Patarroyo ME

Modified merozoite surface protein-1 peptides with short alpha helical regions are associated with inducing protection against malaria.

EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270, 3946-3952 dx.doi.org/10.1046/j.1432-1033.2003.03780.x
Fernández-Real JM, Peñarroja G, Richart C, Castro A, Vendrell J, Broch M, López-Bermejo A, Ricart W

G protein beta3 gene variant, vascular function, and insulin sensitivity in type 2 diabetes.

Hypertension, 2003, 41, 124-129 dx.doi.org/10.1161/01.HYP.0000042428.24031.73
Fernández-Real JM, Ricart W

Insulin resistance and chronic cardiovascular inflammatory syndrome.

ENDOCRINE REVIEWS, 2003, 24, 278-301 dx.doi.org/10.1210/er.2002-0010
Roberts R, Brugada R

Genetics and arrhythmias.

ANNUAL REVIEW OF MEDICINE-SELECTED TOPICS IN THE CLINICAL SCIENCES, 2003, 54, 257-267 dx.doi.org/10.1146/annurev.med.54.073002.182112
Sierra AY, Barrero CA, Rodriguez R, Silva Y, Moncada C, Vanegas M, Patarroyo MA

Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides.

Vaccine, 2003, 21, 4133-4144 dx.doi.org/10.1016/S0264-410X(03)00455-9
Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, Bardaji A, Ricart W, Richart C

A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients.

Atherosclerosis, 2003, 167, 257-264 dx.doi.org/10.1016/S0021-9150(02)00429-X

Coneix l’IDIBGI!

menu